SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-138993
Filing Date
2015-04-21
Accepted
2015-04-21 06:16:00
Documents
3
Group Members
ARNOLD L. ORONSKYBRUCE A. CLEVELANDDOUGLAS A. PEPPERGILBERT H. KLIMANINTERWEST MANAGEMENT PARTNERS IX, LLCKHALED A. NASRNINA S. KJELLSONPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13D d910721dsc13d.htm SC 13D 210044
2 EX-A d910721dex99a.htm EX-99.A 9392
3 EX-C d910721dex99c.htm EX-99.C 25353
  Complete submission text file 0001193125-15-138993.txt   246765
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Subject) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88797 | Film No.: 15781767
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Partners IX, LP (Filed by) CIK: 0001398928 (see all company filings)

IRS No.: 202312479 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D